The enteropathogenic Escherichia coli (EPEC) multicargo chaperone CesT interacts with at least 10 effector proteins and is central to pathogenesis. CesT has been implicated in coordinating effector hierarchy, although the mechanisms behind this regulation are poorly understood. To address this question, we set out to functionally characterize CesT with respect to roles in (i) effector binding, (ii) effector recruitment to the type III secretion system (T3SS), and (iii) effector translocation into host cells. A CesT variant expression library was screened in EPEC using a newly developed semi-high-throughput secretion assay. Among many deficient CesT variants, a predominant number were localized to a novel CesT C-terminal region. These CesT C-terminal variants exhibited normal effector binding yet reduced effector secretion levels. Structural correlation and thermal spectroscopy analyses of purified CesT variants implicated multiple surface-exposed residues, a terminal helix region, and a flexible C-terminal triple-serine stretch in effector secretion. Site-directed mutagenesis of the flexible CesT C-terminal triple-serine sequence produced differential effector secretion, implicating this region in secretion events. Infection assays further indicated that the C-terminal region of CesT was important for NleA translocation into host cells but was dispensable for Tir translocation. The findings implicate the CesT C terminus in effector secretion and contribute to a model for multiple-cargo chaperone function and effector translocation into host cells during infection.
M
any pathogenic bacteria use a type III secretion system (T3SS) to rapidly inject effector proteins into host cells during infection. Effector proteins are synthesized in the bacterial cytosol and are trafficked across the bacterial inner and outer membranes and eventually across the host cell membrane (reviewed in reference 1). Effectors then function to target and subvert host cellular processes often to aid bacterial survival. Effector translocation into host cells is therefore a complex process that requires a macromolecular T3SS structure, which is thought to span three biological membranes when fully assembled.
Additional bacterial proteins are considered ancillary to the T3SS ultrastructure but are critical factors for its biological function to inject effectors into host cells during infection. Type III secretion chaperones (T3SC) do not form part of the T3SS ultrastructure per se, although their substrate binding and docking roles at the base of the assembled T3SS are thought to be key events that support effector translocation during infection (2) (3) (4) . Three classes of T3SC have been identified. There are T3SC that bind effectors (class I), translocon or pore-forming proteins (class II), and needle proteins (class III). Generally, class III needle protein T3SC are thought to prevent premature association or polymerization of monomeric needle proteins within the bacterial cytoplasm (5) . Class II T3SC of translocon proteins bind their cargos within the bacterial cell and in many cases are required for translocon protein secretion (6) . For effector binding class I T3SC, there are two subclasses: IA and IB (7) . Class IA T3SC are thought to bind a single effector, whereas class IB T3SC bind to several effectors. Crystal structures of class IA T3SC from different pathogens display remarkable structural similarity, often forming stable dimers along a helical interface (8, 9) . There is a notable absence of significant sequence similarity, although structural folds appear to be well conserved, as T3SC generally exhibit a secondary structure of ␣-␤-␤-␤-␣-␤-␤-␣. As a group of proteins, T3SC are small (15 to 20 kDa) and acidic (pI 4 to 5) and remain within the bacterial cell even after effector cargo has been translocated into a host cell during infection (a possible exception is Spa15 of Shigella [10] ).
The initial discoveries of T3SC from several laboratories suggested that dedicated or cognate chaperone-effector pairings were common. This was supported by the observation that the genes for the cognate pair were often adjacent to each other and typically shared common transcriptional regulatory control (7, 11, 12) . Later on, it became evident that some T3SC bind to multiple effector proteins (reviewed in reference 13). These class IB or multiple-cargo chaperones have been identified and characterized from different bacteria, including pathogenic Escherichia coli (CesT), Shigella (Spa15), Salmonella (InvB and SrcA), Chlamydia (McsC), and Xanthomonas (HpaB) (4, (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) . Given that these multiple-cargo chaperones contribute to the biological function of various effectors, it is likely that they play a significant role during infection. This view is supported by the fact that T3SC null mutants are often attenuated in relevant animal or plant models of infection (11, 19, 23, 24) .
T3SC have been reported to have a range of functional properties, including roles in transcriptional activation (25, 26) , pro-tein stability (21, 27, 28) , and recruitment or "docking" actions at the base of the T3SS apparatus near the bacterial inner membrane (4, 29) . It has also been shown in the case of Yersinia that SycE chaperone binding to its partner effector YopE results in a localized conformational change in YopE from a disordered to an ordered state (30) . The resulting conformational change is thought to be favorable for presenting YopE to a component of its T3SS (31) (32) (33) .
The chaperone for E. coli secreted protein Tir, CesT, is encoded within an ϳ35-kb pathogenicity island termed the genetic locus of enterocyte effacement (LEE), which is found in attaching and effacing pathogenic E. coli strains (34) . CesT was first reported and categorized as a class IA T3SC (21, 22) , although later work demonstrated that it also interacts with the enteropathogenic E. coli (EPEC) effector Map (14) . In vitro cell line and animal models of infection have demonstrated that CesT contributes to effector translocation into host cells and is essential for efficient host colonization (21, 24, 35) . With the discovery of additional effector proteins encoded outside the LEE pathogenicity island (24, 36) , CesT was further shown to bind many non-LEE-encoded (Nle) effectors, and hence it is best categorized as a multicargo T3SC chaperone (4) . CesT is known to interact with Tir, Map, EspF, EspH, NleA, EspG, NleG, NleH, NleH2, and EspZ (4, 14, 37) . The only other class I T3SC of EPEC is CesF, which binds to EspF (38) . It is not known why EspF interacts with both CesT and CesF. The absence of additional EPEC T3SC for its arsenal of effectors (at least 21) (36) is puzzling, since other pathogens often display distinct chaperone-effector pairings (e.g., Yersinia [YopE/SycE, YopT/SycT, YopO/SycO, and YopH/SycH], Salmonella [SptP/ SicP and SigD/SigE], and Shigella [IcsB/IpgA and IpgD/IpgE]). There is the possibility that CesT represents a "general-purpose" multiple-cargo T3SC or, alternatively, that additional EPEC T3SC exist but remain to be discovered.
CesT (156 amino acids [aa]) forms stable 34.5-kDa homodimers in solution as determined by equilibrium sedimentation analysis (8) . Furthermore, static light scattering experiments with a Tir/CesT complex indicated that CesT binds to Tir in a probable 2:1 ratio. A degenerate chaperone binding domain (CBD) has been identified within some EPEC effectors, which partially addressed how CesT physically interacts with different effector proteins (39) . Mutational analyses have implicated certain CesT amino acid residues and a coiled-coil domain in substrate binding to its prototypic effector partner Tir (8, 40) . CesT has been implicated in mediating hierarchical effector secretion, although the underlying mechanism remains unknown (39) . Here, using a CesT variant expression library and a newly designed functional secretion assay, we have identified a novel C-terminal region of CesT (absent from other T3SC) as an important factor in EPEC effector secretion.
MATERIALS AND METHODS
Growth of bacterial strains. The bacterial strains used and generated in this study are listed in Table 1 . Bacteria were routinely cultured in Luria broth (LB) (1% [wt/vol] tryptone, 0.5% [wt/vol] yeast extract, 1% [wt/ vol] NaCl) at 37°C. Antibiotics (Sigma) were added when appropriate to a final concentrations of 50 g/ml kanamycin, 50 g/ml streptomycin, 30 g/ml chloramphenicol, 200 g/ml ampicillin, and 10 g/ml tetracycline.
Recombinant DNA techniques. The pCesT plasmid was generated by cloning a DNA fragment carrying the cesT allele into the mobilizable broad-host-range plasmid pRK415 (41) . Briefly, primers CesTFOR2 and CesTREV (Table 2) were used in a PCR with EPEC genomic DNA as the template. The resulting fragment was cloned into Eco53kI-treated pRK415 to generate pCesT. A sequence of a suitable ribosome binding site was also included (within primer CesTFOR) to ensure CesT expression. This recombinant construct expresses untagged CesT, transcribed from the lac promoter within the pRK415 vector. Our efforts to generate a plasmid that encodes CesT from the native cesT LEE5 EPEC promoter were not successful for unknown reasons (data not shown).
A cesT1 strain expressing CesT(S147A) from the cesT chromosomal locus was generated by replacing the cesT allele using allelic exchange as previously described (42) . Briefly, two separate PCRs with primer pairs NT265-NT247 and NT266-NT246 were performed, each using pCesT as the template DNA. Phusion DNA polymerase was used to generate bluntended DNA amplification products that were subsequently purified, treated with T4 polynucleotide kinase, and blunt-end ligated with T4 DNA ligase to generate DNA hybrids. The ligated DNA served as the template in a PCR with primers NT265 and NT266. The resulting amplicon that formed cesT(S147A) was digested with SacI and KpnI, followed by cloning into SacI-and KpnI-treated pRE112. The resulting pRE112-based suicide construct (p⌬S147A) was mated into wild-type and ⌬sepD mutant EPEC and subjected to allelic exchange followed by sucrose selection. Individual cesT1 or ⌬sepD cesT1 clones were identified by PCR and DNA sequencing analyses. A similar approach with cloning and allelic exchange was used to generate the ⌬sepD cesT2 mutant, which expresses CesT(H128R) from the cesT chromosomal locus. All newly generated DNA constructs in this study were sequenced at the McGill University and Genome Quebec Innovation Centre.
EP-PCR and site-directed mutagenesis of the cesT allele. A cloned wild-type EPEC cesT allele (468 bp) within pCesT was used as the DNA template in error prone PCR (EP-PCR) to generate a variant cesT allele library. EP-PCR was carried out with Taq DNA polymerase (NEB Canada, catalogue number M0273L) and MnCl 2 under conditions empirically demonstrated to generate 1 mutation in approximately 450 bp of extension products (43) , with some modifications. An EP-PCR buffer (10ϫ; 70 mM MgCl 2 , 500 mM KCl, 100 mM Tris-HCl, 0.01% [wt/vol] gelatin, pH 8.3) was used with the following recipe for a 100-l mixture: 10 l of 10ϫ EP-PCR buffer, 100 pmol of primer cesTmut-FOR, 100 pmol of primer cesTmut-REV, 100 ng pCesT, 2 l of 10 mM deoxynucleoside triphosphate (dNTP), 1.6 l of 10 mM dCTP, 1.6 l of 10 mM dTTP, 1 l of Taq DNA polymerase, 1.5 l of 10 mM MnCl 2 , and 79.3 l of distilled water (dH 2 O). The reaction mixture was divided into 10 tubes (10 l each) to prevent overrepresentation of single mutations in the library. The tubes were subjected to the following thermocycling conditions on an Eppendorf Mastercycler: 95°C for 3 min; 20 cycles of 94°C for 30 s, 50°C for 45 s, and 72°C for 1 min); and 72°C for 5 min. At the end of the thermocycling, the individual reaction mixtures were pooled and frozen at Ϫ20°C. This was repeated 9 mores times to generate a large library of mutated cesT DNA fragments. The entire collection of mutated cesT DNA fragments (approximately 1 ml) was combined and then purified using a Qiagen PCR purification kit. The purified DNA fragments were treated with SacI and EcoRI and ligated to into pRK415 treated with the same enzymes. The entire ligation mixture (in aliquots) was heat shocked into chemically competent DH5␣, followed by selection of transformants on tetracycline medium. Approximately 10,000 transformants were isolated to establish a CesT variant expression library. Using this cloning strategy, directionally cloned cesT alleles would be transcribed from the lac promoter within pRK415. These transformants were then used in triparental matings to mobilize the recombinant plasmids into the ⌬sepD ⌬cesT mutant for phenotypic analyses (see section below).
To generate site-specific mutations, a ligation PCR strategy using oligonucleotides with the desired mutations ( Table 2 ) was used. The mutations were introduced either using engineered in-frame restriction enzyme recognition sequences or by blunt end ligations. Briefly, for each site-specific mutation, Phusion DNA polymerase (Finnzymes) was used with pCesT as the DNA template to generate two PCR products. The PCR products were mixed together, purified, and then treated with the corresponding restriction enzyme or T4 polynucleotide kinase (if blunt-end ligation was required). The digestions or kinase reaction mixture was heat inactivated and then treated with T4 DNA ligase for 1 h at room temperature. The resulting ligation reaction mixture was diluted 10-fold and then used as the template in a PCR with primers cesTmutF and cesTmutR. The resulting PCR products were digested with SacI and EcoRI and then directionally cloned into pRK415. Following transformation into DH5␣, recombinant plasmids were screened for the engineered restriction site as determined by restriction enzyme digestion. All site-directed mutagenesis plasmid constructs were verified by sequencing and then mobilized into appropriate EPEC strains by conjugation.
Semi-high-throughput conjugation to generate a CesT variant expression library. A triparental mating was performed to mobilize the cesT allele library into the EPEC ⌬sepD ⌬cesT double mutant. Briefly, variant cesT alleles cloned into pRK415 and hosted within DH5␣ (donors) were grown overnight in LB within 96-well plates. The next day, 100 l of molten LB agar was added to each well of a new 96-well plate to create a solid nutrient surface favorable for conjugation. Portions of 25 ml of overnight cultures of E. coli MT616 (conjugative helper) and EPEC ⌬sepD ⌬cesT (recipient) were mixed together and pelleted by centrifugation, followed by resuspension in 12.5 ml of fresh LB. Fifty microliters of the helper-recipient mixture was added to each well of the 96-well LB agar plate. Twenty-five microliters of each donor strain was added to individual wells using a multichannel pipettor. The 96-well plate was incubated at 37°C for 1.5 h. Two hundred microliters of fresh LB was added to each well to resuspend the bacteria. A pipette tip-loaded multichannel pipettor was then dipped into the wells of the plate and then used to inoculate a fresh 96-well plate containing liquid LB with streptomycin and tetracycline to select for recipient strains that had received the donor plasmid encoding tetracycline resistance. This growth medium also selected against donor and helper strains as determined by control experiments. After overnight growth, the individual cultures were streak purified onto LB agar petri plates with streptomycin and tetracycline. Streak-purified single colonies were inoculated in multiwell plates with LB plus antibiotics, followed by another incubation at 37°C to establish the CesT variant expression library. Glycerol (15%, vol/vol) was added to the multiwell plates, followed by freezing at Ϫ80°C until expression studies.
In vitro and semi-high-throughput secretion assays. A standard in vitro secretion assay protocol (in 6-well microplates) was performed as previously described (4) . For secreted protein and whole-cell lysate analyses by SDS-PAGE and immunoblotting, the standard protocol was used. For semi-high-throughput assays, the standard protocol was modified so that quantitative absorbance values could be obtained using a modified Bradford protocol (44) . Briefly, overnight cultures of EPEC strains were subcultured (1/50) into 24-well plates. Each well contained 1 ml of prewarmed Dulbecco modified Eagle medium (DMEM) (Invitrogen). The plate was incubated for 6 to 6.5 h at 37°C and 5% CO 2 with static growth. Eight hundred microliters of each culture was pelleted (5 min at 13,200 rpm; Eppendorf 5424) in microcentrifuge tubes. Exactly 500 l of the resulting supernatants was quickly transferred to cuvettes containing 500 l Coomassie blue protein assay reagent (Thermo Scientific, product number 1856209). The supernatant-Coomassie blue reagent mixtures were gently mixed and incubated at room temperature for 20 min. The cuvettes were then placed in an Eppendorf Biophotometer set to read absorbance at 595 nm. A 1:1 mixture of DMEM-Coomassie blue reagent served to blank the instrument. The ⌬sepD, ⌬sepD ⌬cesT, and ⌬sepD ⌬cesT/pCesT strains were included in each plate assay as controls. Readings were taken twice to assess reproducibility of the absorbance values (see Fig. S1 in the supplemental material for a flowchart of the assay). A standard curve for bovine serum albumin-diluted DMEM was generated to determine the linear range of the modified Bradford assay. The assay as performed (500 l of secreted fraction sample mixed with 500 l of reagent) fell within the linear range of detection. Typical values for absorbance of EPEC ⌬sepD were 0.35 to 0.4, corresponding to 15 to 20 g/ml of protein. EPEC strains with deficiencies in CesT function typically produced a secreted fraction absorbance of 0.2 to 0.3, or 5 to 10 g/ml protein.
Bioinformatic analysis and structure-function correlation of CesT variants. Selected CesT variants (from a subset of 142 isolates) were followed up with detailed analyses. The rationale for selection was based on grouping the 142 encoded CesT variants into three separate and identifiable groups: (i) CesT dimerization interface, (ii) surface exposed on the CesT homodimer, and (iii) potential CesT intramolecular interaction. Cases where multiple mutations in the cesT allele were observed were not followed up (a few isolates were followed to learn more about isolates with single mutations that were in common). Representative sets of isolates were selected for detailed biochemical analyses and form the data within this report. All structure-function analyses was carried out on the nuclear magnetic resonance (NMR) spectroscopy-derived CesT homodimer structural model (the Protein Data Bank [PDB] coordinate file was kindly provided by Markus Zweckstetter, Max Planck Institute for Biophysical Chemistry, Göttingen, Germany) (45) , based upon the domain-swapped X-ray structure of E. coli CesT (PDB entry 1K3E). Structural analysis was not carried out on sections of the CesT homodimer involved in the domain swap in the original crystal structure. Instead, inferences about surface accessibility and residue positioning were made, where possible, by considering the proximal unswapped portion of CesT. Molecular visualization and image production were performed using MacPyMol (Schrödinger LLC, Portland, OR).
Protein sequences were subjected to COBALT (constraint-based alignment tool) (46) , which uses conserved domain database (CDD) information along with PROSITE protein motif database information to produce multiple-sequence alignments.
EPEC type III effector translocation assays. A quantitative assay for Tir-mediated actin reorganization (binding index) was performed on HeLa or HT29 cells using the method described by Vingadassalom et al. (47) , with detection by fluorescent phalloidin staining as previously described (42) . To detect Tir and NleA protein translocation resulting from EPEC infection, HeLa cells were mechanically fractionated and immunoblotted with appropriate antibodies, as previously demonstrated (48) . All translocation experiments were performed at least three times, with representative data shown.
CesT-type III effector protein binding assay. A CesT affinity column binding assay was performed as previously described (39) . Freshly purified His-CesT was exposed to 1 ml of filtered (0.22-m pore size, low protein binding; Millipore) ⌬sepD culture supernatant, which contains an abundance of secreted EPEC type III effectors (49) . After 1 h of rotation on a Labquake rotator at room temperature, the microcentrifuge tubes were centrifuged (3,000 rpm; Eppendorf 5415D) to pellet the resin. Unbound proteins (supernatant) were removed, followed by three washes with wash buffer to reduce nonspecific protein or resin interactions. Empty resin (no His-CesT) served as a control. Bound proteins were coeluted from the resin (with His-CesT). The eluted fractions were precipitated using trichloroacetic acid and processed for SDS-PAGE.
Protein overexpression and purification. Recombinant plasmids with various cloned cesT alleles were introduced into E. coli BL21(DE3). Bacterial strains were cultured in LB at 37°C (200 rpm) until reaching an optical density at 600 nm (OD 600 ) of 0.6 and then induced for protein expression by adding 0.1 mM isopropyl-␤-D-thiogalactopyranoside (IPTG). Cultures were further incubated for 2.5 h, followed by harvesting the bacterial cells by centrifugation. The resulting bacterial pellets were either used immediately or stored at Ϫ20°C.
Soluble histidine-tagged CesT and CesT variants were purified using Ni-nitrilotriacetic acid (NTA) resin (Qiagen) as previously described (4) .
Differential scanning fluorimetry (DSF) analyses. Purified His-CesT or His-CesT variants were used at a final concentration of 1 M in 20 mM phosphate buffer (pH 7.5), 150 mM NaCl, and 10 mM EDTA. One microliter of a 25ϫ Sypro orange solution (Invitrogen) was added to the respective sample reactions. Reaction mixtures were added in 25-l volumes to glass capillaries and placed onto a LightCycler 2.0 instrument (Roche Diagnostics). Melting curve analysis was performed by increasing the temperature from 37°C to 95°C with a ramp rate of 0.05°C/s. During thermal denaturation, continuous fluorescence was captured in all channels. Data were analyzed by using melting temperature (T m ) analysis software provided by the manufacturer (version 4.05). The raw data captured from the 610-nm channel were exported and reanalyzed using the Multicode-RTx analysis software version 1.6.4.1 (Eragen BioSciences). Threshold values for baseline fluorescence were set to values obtained for the negative controls (Sypro orange alone and proteins alone). Crystalline hen egg lysozyme (Sigma) dissolved in the same reaction buffer was used as a control.
Protein and immunoblotting techniques. SDS-PAGE was carried out by the method of Laemmli (50) with minor modifications using a Bio-Rad mini-Protean system under constant voltage. Protein transfer to membrane supports (polyvinylidene difluoride [PVDF]; Millipore) was performed using a semidry transfer apparatus operating at 15 V, and immunoblotting was carried out as previously described (42) . Antibodies were used at the following dilutions; anti-EscJ, 1:500 (51); anti-FLAG, 1:10,000 (Sigma); anti-RNA polymerase, 1:2,000 (Santa Cruz Biotechnology); anti-calreticulin, 1:5,000 (Calbiochem); antitubulin, 1:5,000 (Calbiochem); anti-Tir, 1:1,000 (39); goat anti-mouse conjugated to horseradish peroxidase (HRP), 1:5,000 (Rockland Immunochemicals); goat anti-rabbit conjugated to HRP, 1:5,000 (Rockland Immunochemicals); and goat anti-rat conjugated to HRP, 1:5,000. Monospecific affinity-purified antiCesT antibodies raised against a synthetic peptide (LENEHMKIEEISSS DNK) that corresponds to the C-terminal region of CesT (42) were used at a 1:10,000 dilution. For immunoblot detection, an Immun-Star WesternC kit (Bio-Rad) was used as directed by the manufacturer. Chemiluminescent signals were captured using a Bio-Rad VersaDoc MP5000 as previously described (42) and normalized to control protein signals within the same sample. All measurements were made within the linear range of detection for each antibody and processed for densitometry using Image Lab software (version 4.1).
RESULTS
Development of a new semi-high-throughput secretion assay to evaluate CesT function. Bioinformatics approaches have been effective at identifying effectors and T3SC within bacterial genomes (52-54) although there are currently no functional screens that effectively assess T3SC function in vivo. We therefore set out to design a genetic and biochemical screen to assess CesT function in EPEC. The secretion profiles of cesT mutants contain considerably reduced amounts of effector proteins (4) . Furthermore, in a ⌬sepD genetic background, which is known to support high levels of effector secretion, the additional deletion of cesT (i.e., ⌬sepD ⌬cesT) results in bacteria that are deficient in effector secretion (4) . The sepD mutant also has low-level translocator secretion, which is critical to this assay since normal levels of translocator secretion would obscure any decreased effector levels. Therefore, we took advantage of the reduced effector protein amounts within culture supernatants of a ⌬sepD ⌬cesT double mutant and used this strain to express a CesT variant library generated by errorprone PCR. Typically, to evaluate EPEC in vitro type III secretion, we and other groups have precipitated culture supernatants and assessed protein profiles by SDS-PAGE. Such an approach was not feasible for a library screen. We therefore developed a protocol to quantitatively measure total protein amounts in culture supernatants using a common Coomassie blue dye binding assay (see Materials and Methods). Culture supernatants of ⌬sepD, ⌬sepD ⌬cesT, and ⌬sepD ⌬cesT/pCesT strains were collected, clarified by centrifugation, and then added to Coomassie blue dye. The amount of protein in the sample was determined by measuring the OD 595 . As shown in Fig. 1A , the ⌬sepD ⌬cesT double mutant exhibited a significant reduction in protein amount in culture supernatants compared to the ⌬sepD strain (ϳ65% reduction). Genetic complementation of ⌬sepD ⌬cesT with a plasmid expressing CesT restored the total secreted protein amount to 85% compared to that for ⌬sepD, indicating that under these conditions, CesT contributed to the protein amounts observed in culture supernatants and confirming previous findings (4) . With this biochemical assay optimized, we proceeded to use conjugation to mobilize and establish a CesT variant plasmid library in the ⌬sepD ⌬cesT strain. Using a semi-high-throughput secretion assay protocol, we eval-uated 1,092 different isolates and quantitatively determined protein amounts in culture supernatants. Approximately 68% of the CesT variants showed a deficiency in restoring protein amounts in culture supernatants back to ⌬sepD ⌬cesT/pCesT levels (Fig. 1B , which shows data for 200 isolates). These data suggest that this new semi-high-throughput approach was useful in identifying CesT variants deficient for CesT function.
Isolation and characterization of CesT variants deficient in supporting type III secretion. The strains that displayed reduced protein amounts in culture supernatants were isolated from the library and further characterized (n ϭ 739) (see Fig. S2 in the supplemental material for a graphical summary of the data). There still remained the possibility that a ⌬sepD ⌬cesT strain could harbor a plasmid with a missense mutation in cesT (brought about by error-prone PCR) or that the CesT variant was unstable, not expressed at all, or expressed at levels below those for normal CesT. To identify clones that expressed a CesT variant and displayed reduced amounts of secreted proteins in culture supernatants, whole-cell lysates of the isolated clones were assayed for CesT protein levels using immunoblotting with anti-CesT antibody. Using this approach, we determined that 92% (n ϭ 680) of the clones with reduced protein amounts in culture supernatants did express a CesT variant ( Fig. 2A shows an example) . A few clones displayed slower CesT migration in SDS-PAGE, a feature that has been observed before for other CesT variants (8) . Rarer cases of CesT variants with faster migration in SDS-PAGE were also observed ( Fig. 2A) . To assess effector steady-state intracellular levels, whole-cell lysates (harvested after 6 h postinoculation in DMEM) were probed with anti-Tir and anti-NleA antibodies. These two effectors are known to interact with CesT (4). Some ⌬sepD ⌬cesT strains expressing CesT variants had marked reductions in Tir intracellular steady-state levels compared to that supported by wild-type CesT (Fig. 2B) . Immunoblotting with antiNleA polyclonal sera was challenging due to background signals, although it was possible to determine that NleA intracellular levels were reduced for all ⌬sepD ⌬cesT strains expressing CesT variants compared to normal CesT. We considered these altered Tir and NleA steady-state intracellular levels as phenotypic evidence for altered CesT function (discussed in context of CesT substitution below).
Under secretion-inducing conditions, the most abundant proteins within EPEC ⌬sepD culture supernatants are effector proteins (49) . Importantly, mass spectrometry analyses have characterized and identified the protein species (4, 39) . Therefore, ⌬sepD secreted protein profiles (and genetic derivatives) can be compared with respect to protein species content and abundance. From the 680 isolates, 100 random isolates were selected, and their secreted proteins were compared to those of the ⌬sepD ⌬cesT/ pCesT strain by Coomassie blue staining and immunoblotting. Some isolates were found to not support efficient effector secretion and appeared to be similar to the ⌬sepD ⌬cesT strain, whereas others demonstrated an overall reduced level of effector secretion compared to that for the ⌬sepD ⌬cesT/pCesT strain (Fig. 2D shows data for 12 selected isolates). The majority of isolates demonstrated a pattern of differential effector secretion, that is, where the levels of Tir effector were reduced and NleA effector was absent as detected by immunoblotting of secreted protein fractions ( Fig. 2E and F) .
Allelic replacement of chromosomal cesT with modified cesT alleles validates the library screen. trans-complementation of the ⌬sepD ⌬cesT mutant strain with a plasmid expressing CesT restored secretion efficiency to ϳ85% of that for the ⌬sepD strain (Fig. 1A) , and the phenotypic characterization of strains expressing trans-complemented CesT variants showed altered secretory profiles (Fig. 2D) . To validate our genetic screen and to rule out overexpression and plasmid expression artifacts, we generated ciscomplemented strains by replacing chromosomal cesT with altered cesT alleles. Instead of CesT(S147G), we generated the ⌬sepD cesT1 strain, expressing CesT(S147A) (discussed for other experiments described below), and the ⌬sepD cesT2 strain, expressing CesT(H128R). As expected, these strains exhibited similar altered secretory phenotypes (Fig. 3A and B) compared to the ⌬sepD ⌬cesT trans-complemented strains. These data suggest that the library screen was efficient in identifying CesT variants deficient in effector secretion. Therefore, the plasmids from 100 ⌬sepD ⌬cesT mutant strain isolates were collected and subjected to DNA sequencing to determine the corresponding mutation.
Structural correlation analyses locate surface-exposed amino acid residues and a C-terminal region that contribute to CesT function. From the isolated CesT variants deficient in normal effector secretion, we formed three defined groups, based on where the mapped mutation was found on the CesT homodimer: (i) dimerization interface, (ii) surface exposed, and (iii) intramolec- dimerization ( Fig. 4A ) (see Fig. S3 in the supplemental material for additional structural correlation models). In the case of residue E68, it is surface exposed, and hence a replacement by a hydrophobic valine is predicted to disrupt interactions with other T3SS or effector proteins. The change of E68 to valine altered the hydrodynamic properties of soluble CesT in native PAGE compared to those of normal CesT (Fig. 4B , lower band in gel). Serine 119 localizes to the middle of helix ␣3 and a replacement by proline is predicted to disrupt secondary structure. With respect to intramolecular interactions, it is worth noting that the gamma hydroxyl group of serine 119 is in very close proximity to the gamma CH 2 of proline 82 and the aromatic moiety of phenylalanine 76, such that there is no clear need to satisfy an H bond with this serine (a feature that would be disrupted by the proline substitution). CesT(S119P) displayed slower migration in SDS-PAGE ( Fig. 2A and Fig. 4C ) [EPEC and BL21(DE3) lysates, respectively] and was likely insoluble since almost no CesT(S119P) was detected in BL21(DE3) soluble fractions (Fig. 4B) . Amino acid substitutions at H128R and H128Y were identified from the CesT variant library by producing reduced effector secretion levels. H128 is positioned at the end of a well-resolved helical structure (Fig. 4A ) and could interact with other proteins. There is a potential for H128 to be involved in a putative stabilizing "ring" stacking interaction with Y124 (located within 6 Å) in wild-type CesT, although H128R and H128Y would both be able to participate in such an interaction. A ⌬sepD ⌬cesT strain expressing plasmid-encoded CesT(H128R) supported normal intracellular levels of Tir, yet NleA was not detectable within cell lysates (Fig. 2C) . CesT(H128R) supported reduced secreted Tir levels, whereas NleA secretion was not apparent (as detected by immunoblotting analyses) (Fig. 2F) . A ⌬sepD ⌬cesT strain expressing CesT(H128Y) exhibited normal intracellular Tir levels, and NleA was absent. With respect to secreted protein levels, CesT(H128Y) supported reduced and altered Tir secretion, with an appearance of novel degradation products detected with the anti-Tir antibodies (these were absent from the ⌬sepD ⌬cesT/ pCesT strain). Furthermore, and in contrast to CesT(H128R), secreted NleA was detectable when the ⌬sepD ⌬cesT strain expressed CesT(H128Y), although only a lower-molecular-mass form was detected with anti-NleA antisera.
The immediately adjacent N129S substitution (isolated from the screen) results in a less bulky side group, which may alter interactions with other proteins since N129 is likely surface exposed based upon the position of H128 at the end of the resolved ␣3 helix.
Two isolates with substitutions at S147 were identified. CesT(S147G) and CesT(K108E,S147G) demonstrated a differential effector secretion profile, with reduced Tir levels and no NleA. We investigated the C-terminal region surrounding S147 by deleting the last 11 amino acids of CesT (⌬145-156). This truncated strains were isolated and subjected to SDS-PAGE and Coomassie blue staining. Note the reduction of Tir and NleA for the ⌬sepD cesT1 and ⌬sepD cesT2 strains (indicated by arrowheads). EspC is secreted using the type 5 secretion pathway and is not affected. A Bradford assay was used to determine total protein amounts in the respective culture supernatants (bottom). (B) Total secreted proteins and cell lysates were collected and subjected to immunoblotting with the indicated antibodies. Densitometry was performed on the boxed signals for the ⌬sepD strain and then used to normalize the corresponding signals from the other strains.
The normalized values are shown below the blot images. Immunoblotting of whole-cell lysates was performed to assess cellular protein expression levels after 6 h, with the exception of NleA expression, which was measured after 3 h, which helped to reduce background signal levels typically observed in 6-h lysates (see, e.g., Fig. 2C ). RNA polymerase is expected to be unchanged and represents a loading control. EscJ is a ring-forming protein of the T3SS apparatus and was detected to assess expression of the T3SS basal body within each sample. This experiment was performed at least three times, with representative data being shown.
CesT variant was also shown to have a differential effector secretion profile, similar to that for S147G (a reduced Tir level and absent NleA) (Fig. 2D, E, and F) . In summary, amino acids H128, N129, and S147 and the C-terminal 11 amino acids of CesT are implicated in CesT function with respect to effector secretion. CesT variants with amino acid substitutions within the ␣2 dimerization interface exhibited marked reductions in both Tir and NleA steady-state intracellular levels. NleA steady-state levels were reduced or completely absent for all CesT variants evaluated.
Soluble CesT variants dimerize and bind effectors to various extents. Selected mutated cesT alleles were cloned into a T7 promoter expression plasmid (pET28) to produce amino-terminal histidine-tagged CesT variants in E. coli BL21(DE3). All of the CesT variants were expressed at levels comparable to that of HisCesT (Fig. 4C) . Notably, some variants displayed slower migration patterns in SDS-PAGE, while one CesT variant (E35V/ E107G) migrated faster. These findings are consistent with the pattern observed for CesT expression in the EPEC ⌬sepD ⌬cesT strain ( Fig. 2A) . Soluble fractions of the BL21(DE3) lysates were prepared and subjected to nondenaturing (native) SDS-PAGE followed by immunoblotting with anti-His antibodies. Two protein species of approximately 35 kDa and 20 kDa were detected for CesT and most CesT variants (Fig. 4B) . The higher-molecularmass species is consistent with the previous observed formation of CesT dimers (8) , whereas the lower mass is close to the predicted molecular mass of a CesT monomer (17.7 kDa). CesT(E35V/ E107G) and CesT(S119P) were not detected to any extent in native protein gels. The putative CesT(E68V) and CesT(H128R) monomers were found to migrate slower than normal CesT within the native protein gel. CesT E68 is surface exposed, and therefore the loss of negative charge with a replacement by valine likely affected the CesT hydrodynamic properties and hence migration within the gel. CesT H128 is also surface exposed, and the replacement by arginine [CesT(H128R)] results in a positively charged side group with a pK a of 12. This change is expected to alter its migration within the gel. Notably, a variant at the same position [CesT(H128Y)] migrated similarly to wild-type monomeric CesT, presumably due to no change in charge. Lastly, the CesT(K108E/S147G) variant monomer migrated faster in the native gel. This observation may be due to the replacement of lysine 108 by glutamic acid, since the variant with a single replacement of serine 147 by glycine behaved similarly to wild-type CesT. These native (nondenaturing) electrophoretic analyses indicate that most of the CesT variants can form stable dimers and have hydrodynamic properties similar to those of normal CesT.
DSF analyses of CesT and CesT variants. The inherent stabilities of Ni-NTA affinity-column purified His-CesT and His-CesT variants were assessed by differential scanning fluorimetry (DSF) studies. DSF is an accepted spectroscopic technique that monitors thermal unfolding of proteins in the presence of a fluorescent dye. As a protein unfolds with an increase in temperature, the fluorescent dye binds to newly exposed hydrophobic amino acids and emits light at a defined wavelength. It is considered a reliable method to assess protein stability (56) . Some CesT variants were recalcitrant to purification under soluble conditions, so we focused our efforts on the soluble CesT variants.
DSF analysis of purified CesT produced a spectroscopic fluorescence curve with an experimentally derived melting temperature (T m ) of 62.8°C (Fig. 5) . Similar and overlapping fluorescence curves were obtained for CesT variants H128R, N129S, and S147G, with T m values ranging from 62.3 to 62.8°C. CesT(H128Y) had higher fluorescence emission at lower temperature, although as temperature increased, fluorescence emission was similar to that of CesT (see Discussion). In stark contrast, CesT variants P63T, E68V, and K108/S147G produced dramatically shifted curves and lower T m values, ranging from 55 to 56°C. These three less stable CesT variants were deliberately included in the DSF assay, as we predicted them to be less stable due to mutations in the CesT ␣2 dimerization interface. To assess the validity of our experimental approach, we assayed purified hen egg lysozyme as a model protein substrate. A characteristic curve similar to that previously reported was obtained (56) , with a experimentally determined T m of 73.8°C. This value equals the T m for hen egg lysozyme as determined by circular dichroism analysis (57) . These DSF assays indicate that C-terminal CesT variants H128R, N129S, and S147G exhibit protein stability similar to that of normal CesT. Destabilized CesT variants exhibited lower T m values than normal CesT.
C-terminal CesT variants bind effectors similarly to wildtype CesT. The native PAGE experiments and DSF analyses indicated similar hydrodynamic and stability properties for CesT and C-terminal CesT variants. To further assess CesT variant dimer function, we set out to evaluate the ability of certain CesT variants to bind effectors. In our hands, purifying stable, intact, and soluble forms of Tir or NleA (in the absence of CesT) continues to be experimentally challenging. Nonetheless, we have previously shown that purified His-CesT can "capture" multiple EPEC effectors derived from culture supernatants in an in vitro CesT affinity column binding assay (4) . We focused our attention on CesT Cterminal variants [H128R, H128Y, N129S, S147G, and CesT(⌬145-156)], as these constructs exhibited near-normal intracellular levels of Tir within EPEC and retained dimer formation (Fig. 2B and 4B) , two observations consistent with Tir binding and stability. Therefore, normal (wild-type) CesT and these CesT variants were overexpressed and purified from BL21(DE3) lysates using Ni-NTA column chromatography and used in an effector binding assay. Purified CesT efficiently bound and retained multiple protein species from a ⌬sepD culture supernatant as indicated by the absence of specific protein species from column flowthrough fraction (Fig.  6A) . Notably, most EspC protein was not retained and was found within the flowthrough fraction, thus demonstrating CesT affinity column binding for type III secreted effectors, confirming previous results (39) . The CesT(H128R), CesT(N129S), CesT(S147G), and CesT(⌬145-156) flowthrough fractions appeared similar to that for CesT. In contrast, the CesT(H128Y) flowthrough fraction contained small amounts of protein species with molecular masses similar to those found in the ⌬sepD precolumn supernatant, in addition to a novel 10-kDa species. After extensive washing, each of the columns was treated with imidazole to coelute the bound proteins along with His-CesT or His-CesT variant. SDS-PAGE analysis revealed that all of the elution profiles appeared similar by Coomassie blue staining (Fig. 6B) . For unknown reasons, the His-CesT(⌬145-156) variant was less abundant than the other CesT variants, although it was still able to retain effector proteins. Immunoblotting the elution fractions with anti-Tir and anti-NleA antibodies revealed that equivalent levels of these effectors were eluted from the respective columns (Fig. 6B) . Similar results were obtained when reduced amounts of His-CesT or HisCesT variants were exposed to excess amounts of effector proteins (data not shown). These data indicate that CesT C-terminal variants H128R, N129S, S147G, and ⌬145-156 bind effectors similarly to normal CesT. CesT(H128Y) was less efficient at initial binding of effectors but was able to retain effectors similarly to normal CesT. As shown above (Fig. 2E) , CesT(H128Y) expression within the ⌬sepD ⌬cesT strain resulted in reduced intact Tir secretion levels and the appearance of novel Tir species in culture supernatants (see discussion).
Alanine, threonine, and glutamic acid scanning mutagenesis identifies two C-terminal serine residues as important factors in supporting proper CesT functionality. It has been demonstrated that hierarchical Tir translocation occurs during in vitro EPEC infection and that the observed hierarchy is dependent on CesT (37, 39) . Furthermore, a previously characterized CesT(E142G) variant is known to bind Tir but supports reduced Tir secretion. As structural data for the C-terminal region of CesT (amino acids 145 to 156) are lacking and in light of our secretion screen results, we set out to further characterize this region using site-directed mutagenesis. The CesT S147G variant (from the error-prone library) formed the rationale for our mutagenesis approach. Polyserine regions within proteins are known to provide flexibility. We therefore targeted three adjacent serine residues, S145, S146, and S147, for alanine, threonine, and glutamic acid scanning mutagenesis. The rationale was that alanine substitution would not induce any major structural changes and would likely reproduce the CesT(S147G) phenotype. Threonine substitution would be a conservative change owing to polar features and the presence of a hydroxyl side group similar to serine, and lastly, glutamic acid substitution would represent a dramatic change introducing a large, negatively charged amino acid.
Nine CesT variants were generated (Table 2 ) and then introduced into the ⌬sepD ⌬cesT strain for phenotypic characterization. Immunoblotting analysis of the CesT variants demonstrated expression levels equivalent to that of natively expressed CesT in the ⌬sepD strain (Fig. 7A) . Secreted protein fractions were collected, subjected to SDS-PAGE, and stained with Coomassie blue G-250. Replacement of serine 145 by alanine, threonine, or glutamic acid did not have any apparent effect on the secretion profile compared to that of the ⌬sepD ⌬cesT strain expressing wild-type CesT, although a slight reduction in the amount of total secreted protein was evident (Fig. 7B) . In contrast, replacement of serine 146 by alanine, threonine, or glutamic acid resulted in a notable decrease in secreted NleA (Fig. 7A) . Replacement of serine 147 by alanine or glutamic acid strongly reduced NleA secretion, whereas threonine substitution resulted in only a modest decrease in secreted NleA levels. In agreement, a ⌬sepD cesT1 strain expressing CesT(S147A) from the normal cesT allele chromosomal location (cis-complementation) exhibited the same secretion profile (shown in Fig. 3B ) as the trans-complemented strain (Fig. 7A) .
Furthermore, using anti-NleA antibodies, immunoblots of the ciscomplemented CesT(S147A)-expressing strain revealed markedly reduced NleA secreted levels compared to those for the ⌬sepD strain (Fig. 3B) . For all substitutions, Tir secretion levels did not change to any significant extent as determined by band intensity in Coomassie blue-stained gels. The secreted protein fractions were quantified for total protein amount using a Bradford assay. While all the CesT variants supported reduced total protein amounts, the largest reductions were apparent for CesT variants with substitutions at serine 146 and serine 147 (Fig. 7B) . To summarize the site-directed mutagenesis data, CesT serines 146 and 147 contributed to efficient effector secretion, a result that corroborates the deficiency of the CesT(S147G) variant identified from the errorprone PCR CesT expression library (Fig. 2D, E, and F) . Serine 146 had a modest role in effector secretion, whereas serine 145 had a minor role.
The C-terminal region of CesT is important for maximal NleA but not Tir translocation into host cells during infection.
To investigate the ability of CesT variants to direct effector translocation into host cells, an infection assay was carried out to evaluate translocation of the EPEC effectors Tir and NleA into host cells. Initially we screened all the plasmid-expressed CesT variants for their ability to restore Tir-mediated actin pedestal formation to a cesT null mutant. These data demonstrated reduced actin pedestal formation to various extents in all cases (Fig. 8A) . Notably, C-terminal CesT variants H128Y, H128R, and N129S all demonstrated significantly lower numbers of actin pedestals than wild-type CesT (approximately 45 to 60%). Bacteria expressing CesT(S147G) supported modestly reduced actin pedestal formation (89% Ϯ 6%) compared to those expressing CesT (Fig. 8A) . As expected, bacteria expressing CesT(S147A) were found to support pedestal formation similarly to bacteria expressing CesT(S147G) (data not shown).
To investigate if CesT has specific roles for other type III effectors, we evaluated NleA, mainly due to our observation that NleA secretion was absent or reduced for most CesT variants (Fig. 2F) . Upon infection, NleA has been shown to localize to the Golgi The S147A variant appears to secrete Tir but not NleA and validates the S147G library isolate. EspC is a type V secreted protein that is not dependent on CesT and therefore serves as a loading control for each supernatant sample. Bottom, bacterial whole-cell lysates were probed with the indicated antibodies to assess protein expression. EscJ is an inner ring component of the T3SS (not dependent on CesT) and served to indicate equal needle expression among samples. (B) Quantification of total secreted proteins using a Bradford assay. The high and low horizontal bars represent the levels of pCesT complementation and ⌬sepD ⌬cesT, respectively. apparatus, where it is thought to disrupt protein trafficking through COPII-dependent pathways (58) . NleA strictly requires a functional T3SS for translocation into host cells (48) and is known to interact with CesT (4) (Fig. 6B) . Moreover, CesT is not required for nleA gene transcription (39) . We therefore set out to measure levels of NleA translocation into host cells. Unfortunately, our anti-NleA polyclonal rat antibody was not able to detect native NleA levels during infection. For these experiments, we generated strains harboring plasmids expressing epitope-tagged NleA (NleA-FLAG) expressed from the nleA transcriptional promoter. We were unable to use CesT variants expressed from plasmids as the combination of both NleA-and CesT-expressing plasmids reduced the efficiency of EPEC infection of HeLa cells. We therefore generated a strain expressing CesT(S147A) by replacing the normal cesT gene on the chromosome with a corresponding mutated cesT gene, and we named this the cesT1 strain. The rationale to generate a cesT1 strain expressing CesT(S147A) was due to our previous observation that plasmid-encoded CesT(S147A) sup- ported Tir secretion and reduced NleA secretion for a ⌬sepD ⌬cesT mutant (Fig. 7) . The cesT1 strain expressed amounts of EspA, EspB, and EspD (filament and pore-forming proteins) comparable to those expressed by wild-type EPEC (see Fig. S4 in the supplemental material). Importantly, and as expected, the CesT(S147A) variant protein was expressed at levels equal to those of native CesT. These data therefore validate the use of cesT1 strain for CesT(S147A)-related observations. Infected HeLa monolayers were then infected with EPEC ⌬cesT and cesT1 strains expressing NleA-FLAG, followed by fractionation of the infected HeLa cells to detect Tir and NleA translocation levels by immunoblotting. Both the wild-type and cesT1 strains translocated Tir into HeLa cells, as shown by the detection of this effector in the HeLa membrane fraction (Fig. 8B) . In contrast, ⌬cesT did not demonstrate Tir translocation, confirming previous results (21) . The wild type translocated NleA-FLAG into the HeLa cell membrane fraction, whereas the ⌬cesT and cesT1 strains both translocated significantly reduced levels of NleA-FLAG compared to wild type as determined by quantitative densitometry of immunoblot signals. We did note that intracellular (bacterium-associated) NleA-FLAG steady-state levels were reduced for the ⌬cesT and cesT1 strains, although normalization for expression amounts within each strain still revealed lower NleA-FLAG translocation levels.
DISCUSSION
Multicargo chaperones are known to bind different effectors, a process that contributes to pathogenesis, although few studies have investigated how these chaperones coordinate intermolecular interactions and protein trafficking within the bacterial cell.
Previous studies with CesT identified surface-exposed hydrophobic amino acids and a coiled-coil domain as important determinants for substrate interactions (8, 40) . For a relatively small protein, CesT exhibits many surface-exposed hydrophobic amino acids (8) , and therefore it was predicted that those amino acids would be involved in binding interactions with partner proteins. In cases where chaperone-effector cocrystal structures or NMR studies are available, researchers have been guided toward rationale site-directed mutagenesis studies (59, 60) . Unfortunately a CesT-effector cocrystal structure is not available to guide mutagenesis studies. Moreover, Tir is known to strictly require CesT binding for its intracellular stability, so Tir amino acid variants (mutagenesis studies) are often difficult to interpret. We therefore focused our efforts on CesT variants and developed a functional screen for CesT. It was discovered that the C-terminal region of CesT is involved in type III effector secretion. An important observation from this work is that CesT roles in effector binding and secretion are separable events and are likely controlled by different parts of the functional dimer.
CesT differs from other multicargo effector chaperones in that it is larger (156 amino acids). Using protein alignment tools, CesT has been shown to have an additional 20 to 25 amino acids at the C terminus (see Fig. S5 in the supplemental material). Based on alignment algorithms, CesT H128 and N129 are the exact amino acid positions corresponding to the C termini of Spa15 and InvB. Our functional screen resulted in the identification of three functionally deficient CesT variants at this exact location (H128R, H128Y, and N129S), which is indicative of important structural features for this part of the CesT dimer. Since Tir intracellular stability was not compromised for any of these CesT variants, this location may have a role in mediating an appropriate contact with an unidentified component of the T3SS. We found that CesT(H128Y) was less efficient in initial binding of effectors than normal CesT in an in vitro column assay (Fig. 5A ). This finding is in agreement with the observation of an aberrant effector secretion profile for the ⌬sepD ⌬cesT strain expressing CesT(H128Y), which exhibited aberrant Tir-derived polypeptide species and less intact Tir (Fig. 2D) . While we do not know the exact mechanism behind this observation, we do know that purified CesT(H128Y) exhibited increased fluorescence at lower temperatures when analyzed by DSF (Fig. 5) . This may be indicative of increased surface hydrophobicity due to a hydrophobic tyrosine replacing histidine (resulting in increased fluorescence in DSF), or it may suggest localized destabilization within CesT(H128Y) upon thermal denaturation.
The CesT C-terminal region is net positively charged (amino acids 148 to 156, DNKHYYAGR). We speculate that this region may be involved in interactions with other T3SS components. Helical wheel analysis did not demonstrate amphipathic properties within this region (data not shown); however, formation of a ␤-strand would provide a cationic face with the arginine and lysine side chains. It is has been proposed that large tyrosine residues are ideal for mediating molecular contacts and that small serine residues can provide flexibility to short or minimalist binding sites (61) . Our CesT(⌬145-156) variant along with the tripleserine site-directed mutagenesis results, especially for CesTS147, are supportive of this view.
We noticed that the trans-complemented ⌬sepD ⌬cesT double mutant (with pCesT) did not return secretion to exactly ⌬sepD levels. The pCesT plasmid employs the lac promoter to express cesT; therefore, native transcriptional regulatory mechanisms were not restored. For unknown reasons, we were unable to generate a plasmid with the LEE5 promoter that would potentially support "native" cesT expression. Instead, we generated cis-complemented strains for cesT1 and ⌬sepD cesT1, both expressing CesT(S147A), and ⌬sepD cesT2, expressing CesT(H128R). These cis-complemented strains exhibited the same secretion profile as the corresponding CesT variant plasmid trans-complemented strains. These data suggest that the plasmid trans-complementation system, while imperfect, was nonetheless reliable and informative with respect to CesT function.
Comparison of CesT sequences from various pathogenic E. coli strains (enterohemorrhagic E. coli [EHEC] and EPEC) indicates an overall high level of protein sequence identity (95 to 100%) (data not shown). Therefore, CesT is highly conserved, which suggests that CesT function is retained in various pathogenic attaching and effacing E. coli strains. One localized region of difference within CesT is at position 146, where serine is replaced by proline. This is observed in EPEC O157:H45 and EPEC RN587/1, two EPEC strains associated with diarrheal illness. Interestingly, this discrete region of CesT was identified in our mutagenesis screen as being important in supporting effector secretion. We speculate that a structural turn imposed by proline at position 146 serves to present the C-terminal region (aa 147 to 156) to appropriate binding surfaces.
This study reports on the contribution of the C-terminal region of CesT in effector secretion, which is a first for the family of multicargo type III secretion chaperones. The only instance in the literature of a similar observation is found for the related flagellar type III export pathway, where the FlgN chaperone is known to contribute to secretion of the hook filament proteins FlgK and FlgL (62) . FlgN has been demonstrated to interact with the ATPase FliI and also with the C-terminal region of FlhA (an export apparatus component) (3, 63) . Recently, a highly conserved FlgN C-terminal tyrosine residue (Y122) has been implicated in an interaction with FlhA (63) . It is tempting to speculate that a similar protein interaction paradigm applies to EPEC CesT with EscV (FlhA homologue), a question that we will attempt to address in future studies.
It has been demonstrated by several research groups that Tir translocation appears to be a hierarchical process (37, 39, 47) , occurring before other effectors are injected into host cells. Our data indicate Tir secretion even with alteration of CesT at the C-terminal region, whereas in stark contrast, NleA secretion was impaired with CesT alteration. Other EPEC effectors have been shown to be translocated into host cells at reduced levels in the absence of CesT (64, 65) , indicating that CesT contributes to fully competent effector translocation. With respect to effector translocation order, the current data cannot discern the reason for the apparent preference for Tir over other effectors, although we speculate that Tir may have a high affinity for CesT that promotes its hierarchical translocation order. We have been unable to overexpress and purify intact Tir or NleA effector proteins in the absence of overexpressed CesT, an issue that has prevented us from performing appropriate affinity binding studies.
Based on literature from T3SS studies and our own experimental findings, we present hypothetical models depicting CesT in effector trafficking events (Fig. 9) . The needle complex and core export apparatus of the T3SS along with a hexameric ATPase are all required for effector protein secretion and are therefore present in each model. Furthermore, an N-terminal secretion signal is present on effector proteins and has been shown to interact with the T3SS ATPase (66) . CesT-effector complexes have been demonstrated to interact with membranes in the absence of EscN (4), and hence we also present a model where an initial interaction with the membrane occurs, followed by a secondary "on-off" interaction with EscN, to deliver the effector to the T3SS. It is debatable whether T3SS ATPases are stable components of the core T3SS apparatus, as these ATPases have been detected in cytoplasmic fractions but also have a high affinity for membranes (4, 67) . Therefore, another possible model is the formation of an initial tripartite ATPase-chaperone-effector complex. Such complexes have been identified in partially reconstituted in vitro systems (2, 68) . The ATPase-chaperone-effector complex could interact with the inner membrane and then engage the core export apparatus. Importantly, stable YscLNQ and EscLNQ protein complexes have been reported (69, 70) , and therefore all models converge on EscN (ATPase) engagement at the base of the T3SS export apparatus. The ATPase is then postulated to dissociate the chaperone-effector complex and further unfold the effector protein to allow entry into the base of the T3SS (2) . Additional studies are required to refine these models, although we envision that certain effectors might have intrinsic features that contribute to differential secretion efficiencies. These may include cotranscriptional regulation, higher binding affinities, or ordered interactions with key T3SS components and effector stability. There is compelling experimental evidence for each of the models, suggesting that cooperative protein interactions sequentially occur with T3SS components to mediate type III secretion.
In summary, this study presents findings that highlight several roles for the multicargo T3SC CesT. CesT dimerization was demonstrated to be important for its role in stabilizing effectors. Moreover, specific regions of CesT were shown to not be involved in stabilizing events but rather were involved in promoting efficient effector secretion. Lastly, genetic and biochemical approaches provide data that implicate the positively charged C-terminal region of CesT in secretion events. These structure/function findings should be valuable in future studies to discover potential T3SC inhibitor molecules, a strategy that could reduce the disease burden caused by pathogens using the T3SS during infection.
